Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 3 |
Amazon
AMZN
|
+$1.11B |
| 4 |
Airbnb
ABNB
|
+$574M |
| 5 |
NVIDIA
NVDA
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$588M |
| 2 |
NIO
NIO
|
+$539M |
| 3 |
Apple
AAPL
|
+$525M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$443M |
| 5 |
Microsoft
MSFT
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.77% |
| 2 | Consumer Discretionary | 1.94% |
| 3 | Technology | 1.9% |
| 4 | Communication Services | 1.42% |
| 5 | Financials | 1.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPCK
2751
CALL
The SPAC and New Issue ETF
SPCK
$8.3M
| $10.8M | ﹤0.01% |
370,300
-204,100
| -36% | -$5.86M |
|
|
CHX
2752
DELISTED
ChampionX
CHX
| $10.8M | ﹤0.01% |
420,595
+318,581
| +312% | +$7.75M |
|
2753
CALL
Vir Biotechnology
VIR
$1.91B
| $10.8M | ﹤0.01% |
227,800
+19,400
| +9% | +$882K |
|
2754
CALL
DaVita
DVA
$11.4B
| $10.8M | ﹤0.01% |
89,400
-1,300
| -1% | -$154K |
|
2755
PUT
Reliance Steel & Aluminium
RS
$20B
| $10.8M | ﹤0.01% |
71,300
+13,800
| +24% | +$2.24M |
|
2756
PUT
American Water Works
AWK
$27.2B
| $10.8M | ﹤0.01% |
69,800
-39,100
| -36% | -$6.09M |
|
2757
PUT
Scorpio Tankers
STNG
$3.88B
| $10.8M | ﹤0.01% |
487,800
+221,300
| +83% | +$4.5M |
|
2758
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$12.2B
| $10.8M | ﹤0.01% |
78,810
+29,516
| +60% | +$3.99M |
|
2759
CALL
Twist Bioscience
TWST
$9.6B
| $10.8M | ﹤0.01% |
80,700
-7,400
| -8% | -$860K |
|
|
TLND
2760
DELISTED
Talend S.A. American Depositary Shares
TLND
| $10.8M | ﹤0.01% |
163,868
+24,833
| +18% | +$1.61M |
|
|
SDC
2761
PUT
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $10.7M | ﹤0.01% |
1,238,300
+163,500
| +15% | +$1.51M |
|
2762
CALL
POSCO
PKX
$18.5B
| $10.7M | ﹤0.01% |
140,000
+133,700
| +2,122% | +$10.6M |
|
|
SWN
2763
DELISTED
Southwestern Energy Company
SWN
| $10.7M | ﹤0.01% |
1,893,652
+597,397
| +46% | +$2.94M |
|
2764
CALL
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
| $10.7M | ﹤0.01% |
117,300
-9,200
| -7% | -$842K |
|
2765
CALL
United Therapeutics
UTHR
$22.6B
| $10.7M | ﹤0.01% |
59,800
+16,000
| +37% | +$3.05M |
|
|
RDUS
2766
DELISTED
Radius Recycling
RDUS
| $10.7M | ﹤0.01% |
218,304
+136,158
| +166% | +$6.77M |
|
2767
CALL
Aurinia Pharmaceuticals
AUPH
$2.19B
| $10.7M | ﹤0.01% |
826,000
+449,900
| +120% | +$5.73M |
|
2768
PUT
BlueLinx
BXC
$627M
| $10.7M | ﹤0.01% |
212,900
+203,800
| +2,240% | +$10M |
|
2769
CALL
Ocugen
OCGN
$465M
| $10.7M | ﹤0.01% |
1,330,300
+871,400
| +190% | +$7.35M |
|
2770
Agios Pharmaceuticals
AGIO
$2.05B
| $10.7M | ﹤0.01% |
193,552
+183,914
| +1,908% | +$10.3M |
|
|
VXRT
2771
PUT
DELISTED
Vaxart
VXRT
| $10.7M | ﹤0.01% |
1,421,900
+30,000
| +2% | +$209K |
|
|
FAZ
2772
PUT
Direxion Daily Financial Bear 3x ETF
FAZ
$88.9M
| $10.6M | ﹤0.01% |
39,720
+8,190
| +26% | +$2.29M |
|
2773
PUT
Monolithic Power Systems
MPWR
$64.4B
| $10.6M | ﹤0.01% |
28,500
+2,200
| +8% | +$774K |
|
|
CLDR
2774
CALL
DELISTED
Cloudera, Inc.
CLDR
| $10.6M | ﹤0.01% |
670,800
-656,900
| -49% | -$8.93M |
|
2775
PUT
Invesco
IVZ
$14.7B
| $10.6M | ﹤0.01% |
397,600
-56,400
| -12% | -$1.54M |
|
Similar funds
Jeff Yass's Q2 2021 Portfolio in Review
As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
- Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
- Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
- Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
- Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
- Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
- Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.